TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA)

Q: What does CUSIP 881624209 represent in this 13F holders report?

CUSIP 881624209 is the security identifier for TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in Q2 2019?

434 institutional investors reported TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share for Q2 2019. Use the holders table for investor-level position and value details.

CUSIP: 881624209

Q2 2019 13F Holders as of 30 Jun 2019

Security type / class: Equity / Ordinary Shares, par value NIS 0.01 per share
Total 13F shares: 640,277,265
Total 13F value: $5,906,782,225
Share change: -20,324,716
Put/Call ratio: 192%
SEC-reported price per share: $9.23
Number of holders: 434
Value change: -$439,059,091
Number of buys: 196
Number of sells: 234
Shares outstanding: 1,148,777,709

Security key

881624209

Report period

Q2 2019

Institutions

434

Top holders

TEVA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2019 Previous quarter: Q1 2019 TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings TEVA PHARMACEUTICAL INDUSTRIES LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 881624209

Newer quarter: Q3 2019 Previous quarter: Q1 2019

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Capital Research Global I...

Disclosed value leader

Capital Research Global I...

Comparable rows

15/15

Latest evidence

31 Mar 2019

13F Lead comparable stake: 11% Showing 1-6 of 15 holder rows.

Quick read

Capital Research Global Investors leads the comparable SEC ownership view at 11%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Capital Research Global Investors's linked filing trail.

Comparable ownership Top 5

Capital Research Global Investors 11%

FRANKLIN RESOURCES INC 5.6%

WELLINGTON MANAGEMENT GROUP LLP 5.1%

Capital World Investors 4.1%

BERKSHIRE HATHAWAY INC 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Capital Research Global Investors	13F Company 13F	11%	$2,010,041,000 128,191,392 shares	—	31 Mar 2019
FRANKLIN RESOURCES INC	13F Company 13F	5.6%	$1,013,298,000 64,623,884 shares	—	31 Mar 2019
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	5.1%	$917,225,000 58,496,544 shares	—	31 Mar 2019
Capital World Investors	13F Company 13F	4.1%	$731,137,000 46,628,665 shares	—	31 Mar 2019
BERKSHIRE HATHAWAY INC	13F Company 13F	3.8%	$678,149,000 43,249,295 shares	—	31 Mar 2019
BlackRock Finance, Inc.	13F Company 13F	2.9%	$529,710,000 33,782,597 shares	—	31 Mar 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

434

640,277,265

Rows available

434

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

494

Q2 2019 holders

434

Holder diff

-60

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q2 2019 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend